Doppler ultrasound to predict success of conservative or methotrexate treatment for tubal ectopic pregnancy
Official title: Doppler Flow in Tubal Ectopic Pregnancy in Diagnosis as a Predictor of Treatment Success - Conservative and MTX Treatment
Run by Meir Medical Center · NCT07541937 · Data updated 2026-11-12
This project will test whether specific Doppler blood-flow measurements at diagnosis can help predict if conservative management or methotrexate will successfully treat tubal ectopic pregnancy.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 60 (estimated) |
| Sponsor | Meir Medical Center Academic / other |
| Drugs / interventions | methotrexate |
| Locations | 1 site (Kfar Saba, Israel) |
| Status | Recruiting |
| Started | June 1, 2024 |
| Main results expected | June 1, 2027 |
| Study ends | June 1, 2027 |
| Registry record updated | April 21, 2026 |
| Trial ID | NCT07541937 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18–45 with a confirmed tubal ectopic pregnancy who are hemodynamically stable and eligible for conservative management or methotrexate therapy are ideal candidates.
✕Probably not a fit
Patients who are hemodynamically unstable, have suspected tubal rupture, non-tubal ectopic pregnancies, or require immediate surgery are unlikely to benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective study enrolling about 60 women with hemodynamically stable tubal ectopic pregnancies at diagnosis. Investigators will record Doppler ultrasound parameters (resistive index, pulsatility index, and peak systolic velocity) and clinical/laboratory data, then follow patients treated according to standard departmental protocols (conservative monitoring or methotrexate). The primary aim is to see whether Doppler measures at presentation predict treatment success; secondary aims include exploring other factors such as gestational features, pain, bleeding, and beta-hCG levels. Results could clarify whether Doppler vascularization should inform selection of non-surgical management.
Why it matters
Potential benefit: If successful, clinicians could more accurately select patients for conservative or methotrexate therapy, potentially reducing failed medical treatment and the need for surgery.
How similar studies have gone: Previous smaller studies have suggested a link between Doppler vascularization and treatment outcomes, but findings are mixed and there is no widely accepted threshold yet.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * Tubal ectopic pregnancy * Hemodynamically stable, with no suspicion of rupture, * Eligible for MTX or conservative therapy. Exclusion criteria: * Intrauterine pregnancy * Hemodynamic instability * Suspected tubal rupture * Other ectopic pregnancy: CSP, Ovarian, heterotopic pregnancy
Where it's running
-
Meir Medical Center
Kfar Saba, Israel, Israel Recruiting
Study contacts
- Study coordinator: Chen Manor Bar, MD
- Email: manor.chen@gmail.com
- Phone: +972544414211
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PTSD after ectopic pregnancy
This project will test how common PTSD symptoms are in women who have had an ectopic pregnancy by asking them to complete brief questionnaires.
-
Methotrexate for ectopic pregnancy in patients with relative contraindications
This review will see if methotrexate worked safely and effectively for women with ectopic pregnancy who had conditions that make the drug relatively risky.
-
vNOTES versus laparoscopic salpingectomy for ectopic pregnancy
This trial tests whether vNOTES or conventional laparoscopic salpingectomy gives faster recovery, less postoperative pain, and similar safety for women aged 18–55 who need surgery for ectopic pregnancy.
-
Remote follow-up with a connected app after emergency gynecological care
This trial tests if using a secure connected health app for remote follow-up improves satisfaction and clinical outcomes for women aged 18–60 after emergency gynecological visits.
-
Using Letrozole to Treat Ectopic Pregnancy
This study is testing if a daily pill called letrozole can effectively treat early ectopic pregnancies just as well as the usual shot of methotrexate.
-
Effect of early intervention on displaced canine teeth in children
This study is testing if early orthodontic treatment for kids with misplaced canine teeth can help them avoid surgery compared to those who don’t get any treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.